Engineering Immunomodulatory Scaffolds for Dental Pulp Regeneration
用于牙髓再生的免疫调节支架工程
基本信息
- 批准号:10371368
- 负责人:
- 金额:$ 15.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:Anti-Inflammatory AgentsAntibodiesBiocompatible MaterialsCellsDataDentalDental PulpDentinDentistsDevelopmentDisinfectionEndodonticsEngineeringEnvironmentEventFosteringGoalsHydrogelsImmuneImmune TargetingImmune responseImmune systemInfectionInflammatoryLeadLipopolysaccharidesMacrophage ActivationMediatingMediator of activation proteinMentored Research Scientist Development AwardMouth DiseasesNatural regenerationNecrosisPatientsPersonsPhenotypeProcessPropertyPulp CanalsResearchScientistStimulusTherapeuticTissue EngineeringTissue MicroarrayTissuesTooth structureTraining Programscraniofacialcytokineimmunoregulationin vivomacrophagemonocytenanobodiesnovelpathogenprogramsregenerativeregenerative approachresponsescaffoldsuccesstissue regenerationtissue support frametool
项目摘要
PROJECT SUMMARY
This K01 award describes a 3-year training program to support Dr. Franca's transition to scientific
independence. Dr. Franca is a dentist-scientist, and her long-term goal is to lead a research program to (i)
develop immunomodulatory biomaterials for dental and craniofacial regeneration and (ii) to create tissue
chips to understand and treat oral diseases. The scientific goal of this K01 is to develop an
immunomodulatory scaffold for dental pulp regeneration. Despite undeniable progress to develop
regenerative strategies for the dental pulp, necrotic teeth present challenging conditions for regeneration.
Even after careful disinfection, a previously infected root canal's microenvironment has remnant
lipopolysaccharide (LPS) that activates immune cells into a pro-inflammatory state incompatible with tissue
regeneration. Recently, early events of the immune response were shown to highly influence tissue
engineering strategies' success. Especially, macrophage responses to biomaterials have been identified as
essential mediators of scaffold remodeling and promising targets for immune-mediated regenerative
strategies. These cells can respond to external stimuli by changing their phenotype from pro-inflammatory to
pro-regenerative, with many intermediate states, in a process known as M1/M2 polarization. These two states
are highly plastic, function synergistically, and can be modulated by the scaffold's properties. When a scaffold
for dental pulp regeneration is placed in contact with LPS-contaminated dentin, it can be expected that M1
activation will persist without providing the pro-regenerative environment necessary for tissue formation.
Small antibodies or nanobodies have been used to neutralize LPS in Gram-negative infections and target
pathogens in scarcely accessible tissue microenvironments. Unfortunately, this therapeutic tool has not been
used for dental regeneration purposes. Our overarching hypothesis is that an immunomodulatory scaffold
that neutralizes LPS and increases the M2/M1 ratio in the scaffold-tissue interface will provide a sustainable
pro-regenerative microenvironment more favorable to dental pulp tissue formation. Hence, our goal is to
engineer a novel nanobody-laden photocrosslinkable hydrogel with fine-tuned stiffness and the ability to
neutralize dentin LPS. This scaffold will enable controllable guidance of M1 macrophages activation,
minimizing their presence within the root canal so that incoming monocytes can polarize into M2 cells,
infiltrate the hydrogel, and secret an anti-inflammatory cytokine milieu to foster dental pulp tissue formation.
We propose the following aims: (Aim 1) to determine the effect of scaffold's stiffness on M1/M2 macrophage
polarization, (Aim 2) to neutralize dentin LPS and reduce M1 polarization, and (Aim 3) to evaluate the
nanobody-laden scaffold's immunomodulatory capacity in vivo. Successful completion of these aims will
generate data on the interplay between scaffold's properties and macrophage function, forming the basis for
an R01 submission and the development of additional novel immunomodulatory materials.
项目摘要
该K 01奖项描述了一项为期3年的培训计划,以支持弗兰卡博士向科学
独立弗兰卡博士是一名牙医科学家,她的长期目标是领导一个研究项目,以(i)
开发用于牙齿和颅面再生的免疫调节生物材料,以及(ii)产生组织
了解和治疗口腔疾病的芯片。K 01的科学目标是开发一种
用于牙髓再生免疫调节支架。尽管不可否认的进步,
牙髓的再生策略,坏死的牙齿提出了具有挑战性的再生条件。
即使经过仔细消毒,先前感染的根管微环境仍有残留
脂多糖(LPS),激活免疫细胞进入与组织不相容的促炎状态
再生最近,免疫反应的早期事件被证明对组织具有高度影响,
工程战略的成功。特别是,巨噬细胞对生物材料的反应已被确定为
支架重塑的重要介质和免疫介导再生的有希望的靶点
战略布局这些细胞可以通过将其表型从促炎性改变为促炎性来响应外部刺激。
在称为M1/M2极化的过程中,具有许多中间状态的前再生。这两种状态
具有高度的可塑性,协同作用,并且可以通过支架的特性进行调节。当一个脚手架
用于牙髓再生的材料与LPS污染的牙本质接触,可以预期M1
激活将持续存在而不提供组织形成所必需的促再生环境。
小抗体或纳米抗体已被用于中和革兰氏阴性感染中的LPS,并靶向
病原体在难以接近的组织微环境中。不幸的是,这种治疗工具还没有被
用于牙齿再生。我们的首要假设是免疫调节支架
中和LPS并增加支架-组织界面中的M2/M1比率将提供可持续的
促再生微环境更有利于牙髓组织的形成。因此,我们的目标是
设计一种新型的载有纳米抗体的可光交联水凝胶,
中和牙本质LPS。该支架将能够可控地引导M1巨噬细胞活化,
最大限度地减少它们在根管内的存在,使得进入的单核细胞可以进入M2细胞,
渗透水凝胶,并分泌抗炎细胞因子环境以促进牙髓组织形成。
本研究的主要目的是:(1)研究支架刚度对M1/M2巨噬细胞增殖的影响
极化,(目的2)中和牙本质LPS并减少M1极化,以及(目的3)评估
纳米抗体负载支架的体内免疫调节能力。成功实现这些目标将
生成关于支架特性和巨噬细胞功能之间相互作用的数据,为
R 01提交和其他新型免疫调节材料的开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cristiane Miranda Franca其他文献
Cristiane Miranda Franca的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cristiane Miranda Franca', 18)}}的其他基金
Engineering Immunomodulatory Scaffolds for Dental Pulp Regeneration
用于牙髓再生的免疫调节支架工程
- 批准号:
10559644 - 财政年份:2022
- 资助金额:
$ 15.46万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 15.46万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 15.46万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 15.46万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 15.46万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 15.46万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 15.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 15.46万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 15.46万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 15.46万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 15.46万 - 项目类别: